Scholar Rock Holding buy Lifesci Capital
Start price
04.06.25
/
50%
€27.00
Target price
04.06.26
-
Performance (%)
24.44%
Price
15:21
€35.40
Summary
This prediction is currently active. The BUY prediction by Lifesci_Capital currently has a performance of 24.44%. This prediction currently runs until 04.06.26. The prediction end date can be changed by Lifesci_Capital at any time. Lifesci_Capital has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Scholar Rock Holding | 6.918% | 6.918% |
| iShares Core DAX® | 1.867% | 3.031% |
| iShares Nasdaq 100 | 1.427% | 5.634% |
| iShares Nikkei 225® | 5.007% | 9.538% |
| iShares S&P 500 | 1.241% | 4.277% |
Comments by Lifesci_Capital for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock Holding Co. (NASDAQ: SRRK) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Ratings data for SRRK provided by MarketBeat